Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09DBY
|
|||
| Former ID |
DCL000961
|
|||
| Drug Name |
Rilonacept
|
|||
| Synonyms |
Rilonacept (USAN/INN)
Click to Show/Hide
|
|||
| Indication | Arthritis [ICD-11: FA20] | Approved | [1], [2] | |
| Acute gout flare [ICD-11: FA25.0; ICD-10: M10.0; ICD-9: 274] | Phase 3 | [1], [3] | ||
| Company |
Regeneron
|
|||
| PubChem Substance ID | ||||
| ADReCS Drug ID | BADD_D01939 | |||
| SuperDrug ATC ID |
L04AC04
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6790). | |||
| REF 2 | 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6. | |||
| REF 3 | New relief for gout. Nat Biotechnol. 2009 Apr;27(4):309-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.